Sensus Healthcare, Inc. (SRTS)
USD 4.45
(-9.29%)
USD 4.45
(-9.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 30 Thousand USD | -99.8% |
| 2022 | 14.83 Million USD | 269.25% |
| 2021 | 4.73 Million USD | 143.01% |
| 2020 | -6.09 Million USD | -463.51% |
| 2019 | -1.15 Million USD | 8.9% |
| 2018 | -1.2 Million USD | 48.76% |
| 2017 | -3.25 Million USD | -1021.95% |
| 2016 | 13 Thousand USD | -437.69% |
| 2015 | 96.11 Thousand USD | 102.82% |
| 2014 | -3.4 Million USD | -965.43% |
| 2013 | 393.65 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.06 Million USD | -34.04% |
| 2024 Q1 | 3 Million USD | -49.16% |
| 2023 Q4 | 5.63 Million USD | 448.39% |
| 2023 Q1 | -2.93 Million USD | -166.67% |
| 2023 Q2 | -1.12 Million USD | 61.65% |
| 2023 Q3 | -1.61 Million USD | -43.57% |
| 2023 FY | - USD | -99.8% |
| 2022 Q3 | 2.28 Million USD | -50.38% |
| 2022 Q4 | 4.4 Million USD | 93.33% |
| 2022 FY | - USD | 269.25% |
| 2022 Q1 | -8.84 Million USD | -266.33% |
| 2022 Q2 | 4.59 Million USD | 151.93% |
| 2021 Q4 | 5.32 Million USD | 2628.21% |
| 2021 Q3 | 195 Thousand USD | 169.89% |
| 2021 Q2 | -279 Thousand USD | 74.98% |
| 2021 FY | - USD | 143.01% |
| 2021 Q1 | -1.11 Million USD | -122.81% |
| 2020 Q2 | -2.56 Million USD | 28.63% |
| 2020 FY | - USD | -463.51% |
| 2020 Q4 | -500.42 Thousand USD | 78.03% |
| 2020 Q3 | -2.27 Million USD | 11.03% |
| 2020 Q1 | -3.58 Million USD | -445.21% |
| 2019 Q4 | 1.03 Million USD | 242.27% |
| 2019 FY | - USD | 8.9% |
| 2019 Q2 | 112.3 Thousand USD | 105.3% |
| 2019 Q3 | -730.39 Thousand USD | -750.35% |
| 2019 Q1 | -2.12 Million USD | -2181.22% |
| 2018 Q4 | 101.91 Thousand USD | 125.46% |
| 2018 FY | - USD | 48.76% |
| 2018 Q1 | -1.09 Million USD | -185.23% |
| 2018 Q2 | -475.14 Thousand USD | 56.51% |
| 2018 Q3 | -400.34 Thousand USD | 15.74% |
| 2017 Q3 | -946.78 Thousand USD | -45.89% |
| 2017 Q2 | -648.97 Thousand USD | 58.55% |
| 2017 Q1 | -1.56 Million USD | -4195.36% |
| 2017 Q4 | -383.01 Thousand USD | 59.55% |
| 2017 FY | - USD | -1021.95% |
| 2016 Q1 | 97.13 Thousand USD | -80.19% |
| 2016 Q2 | -345.7 Thousand USD | -455.89% |
| 2016 Q3 | -29.44 Thousand USD | 91.48% |
| 2016 FY | - USD | -437.69% |
| 2016 Q4 | 38.22 Thousand USD | 229.83% |
| 2015 Q3 | 5346.00 USD | -31.12% |
| 2015 Q1 | -407.34 Thousand USD | 0.0% |
| 2015 FY | - USD | 102.82% |
| 2015 Q4 | 490.35 Thousand USD | 9072.35% |
| 2015 Q2 | 7761.00 USD | 101.91% |
| 2014 FY | - USD | -965.43% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 100.06% |
| BrainsWay Ltd. | -2.31 Million USD | 101.298% |
| Cerus Corporation | -26.53 Million USD | 100.113% |
| Envoy Medical, Inc. | -18.23 Million USD | 100.164% |
| electroCore, Inc. | -17.76 Million USD | 100.169% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 100.248% |
| IceCure Medical Ltd | -15.25 Million USD | 100.197% |
| Inogen, Inc. | -45.67 Million USD | 100.066% |
| OrthoPediatrics Corp. | -8.38 Million USD | 100.358% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 100.06% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 100.178% |
| MaxCyte, Inc. | -44.12 Million USD | 100.068% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 100.255% |
| Nexalin Technology, Inc. | -5.69 Million USD | 100.527% |
| Orthofix Medical Inc. | -86.98 Million USD | 100.034% |
| PAVmed Inc | -75.74 Million USD | 100.04% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 100.056% |
| RxSight, Inc. | -41.03 Million USD | 100.073% |
| Sight Sciences, Inc. | -49.41 Million USD | 100.061% |
| SI-BONE, Inc. | -34.44 Million USD | 100.087% |
| TELA Bio, Inc. | -40.63 Million USD | 100.074% |
| Treace Medical Concepts, Inc. | -39 Million USD | 100.077% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 100.18% |
| Acutus Medical, Inc. | -13.48 Million USD | 100.222% |
| Talis Biomedical Corporation | -66.04 Million USD | 100.045% |
| Spectral AI, Inc. | -12.26 Million USD | 100.245% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 100.063% |
| CVRx, Inc. | -38.73 Million USD | 100.077% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 100.85% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 100.286% |
| Bioventus Inc. | -23.07 Million USD | 100.13% |
| Venus Concept Inc. | -26.11 Million USD | 100.115% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 100.051% |
| LivaNova PLC | 39.01 Million USD | 99.923% |
| 908 Devices Inc. | -34.02 Million USD | 100.088% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 100.027% |
| Nemaura Medical Inc. | -7.28 Million USD | 100.412% |
| NeuroPace, Inc. | -22.83 Million USD | 100.131% |
| LENSAR, Inc. | -8.71 Million USD | 100.344% |
| Apyx Medical Corporation | -18.11 Million USD | 100.166% |
| Cutera, Inc. | -136.56 Million USD | 100.022% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 100.888% |
| BioSig Technologies, Inc. | -28.15 Million USD | 100.107% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 98.808% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 100.143% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 99.992% |
| Axonics, Inc. | 7.77 Million USD | 99.614% |
| Outset Medical, Inc. | -153.78 Million USD | 100.02% |
| IRIDEX Corporation | -7.44 Million USD | 100.403% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 100.031% |
| IRadimed Corporation | 20.8 Million USD | 99.856% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 100.372% |
| INVO Bioscience, Inc. | -6.88 Million USD | 100.436% |
| Telesis Bio, Inc. | -40.49 Million USD | 100.074% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 99.918% |
| Varex Imaging Corporation | 67.2 Million USD | 99.955% |
| Quipt Home Medical Corp. | 44.07 Million USD | 99.932% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 100.276% |
| Pulmonx Corporation | -55.09 Million USD | 100.054% |
| Dynatronics Corporation | -976 Thousand USD | 103.074% |
| Modular Medical, Inc. | -17.1 Million USD | 100.175% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 100.207% |
| Semler Scientific, Inc. | 23.58 Million USD | 99.873% |
| InMode Ltd. | 196.28 Million USD | 99.985% |
| Bruker Corporation | 599 Million USD | 99.995% |
| Cytosorbents Corporation | -28.81 Million USD | 100.104% |
| DexCom, Inc. | 916.7 Million USD | 99.997% |
| Align Technology, Inc. | 799.03 Million USD | 99.996% |
| Viveve Medical, Inc. | -20.61 Million USD | 100.146% |
| ZimVie Inc. | 91.07 Million USD | 99.967% |
| Movano Inc. | -29.12 Million USD | 100.103% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 100.681% |
| Nexalin Technology, Inc. | -5.69 Million USD | 100.527% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 100.85% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 100.015% |
| Profound Medical Corp. | -27.12 Million USD | 100.111% |
| Insulet Corporation | 323.6 Million USD | 99.991% |
| enVVeno Medical Corporation | -25.01 Million USD | 100.12% |
| Surmodics, Inc. | 1.18 Million USD | 97.475% |
| iCAD, Inc. | -6.56 Million USD | 100.457% |
| Nuwellis, Inc. | -16.35 Million USD | 100.183% |
| Biotricity, Inc. | -8.82 Million USD | 100.34% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 100.031% |
| Aethlon Medical, Inc. | -11.84 Million USD | 100.253% |
| InspireMD, Inc. | -20.91 Million USD | 100.143% |
| PAVmed Inc. | -75.74 Million USD | 100.04% |
| BIOLASE, Inc. | -15.13 Million USD | 100.198% |
| Beyond Air, Inc. | -59.03 Million USD | 100.051% |
| FONAR Corporation | 28.25 Million USD | 99.894% |
| AxoGen, Inc. | -13.32 Million USD | 100.225% |
| Vivani Medical, Inc. | -26.6 Million USD | 100.113% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 99.878% |
| Inari Medical, Inc. | 7.11 Million USD | 99.578% |
| UFP Technologies, Inc. | 72.74 Million USD | 99.959% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 100.886% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 100.487% |
| Tenon Medical, Inc. | -15.52 Million USD | 100.193% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 100.197% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 100.072% |
| AdaptHealth Corp. | -171.09 Million USD | 100.018% |
| Sintx Technologies, Inc. | -6.6 Million USD | 100.455% |
| NanoVibronix, Inc. | -3.43 Million USD | 100.873% |
| Quanterix Corporation | -38.08 Million USD | 100.079% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 100.276% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 100.011% |
| TransMedics Group, Inc. | -7.6 Million USD | 100.395% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 100.138% |
| NeuroMetrix, Inc. | -7.09 Million USD | 100.423% |
| Hyperfine, Inc. | -47.06 Million USD | 100.064% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 100.051% |
| Biomerica, Inc. | -5.99 Million USD | 100.501% |
| Bone Biologics Corporation | 479.57 Thousand USD | 93.744% |
| AVITA Medical, Inc. | -39.56 Million USD | 100.076% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 100.327% |
| Silk Road Medical, Inc | -45.08 Million USD | 100.067% |